The hepatitis B vaccine protects against hepatitis B, a serious disease that damages the liver. The vaccine is one of the recommended childhood immunizations.
Alternative NamesVaccine - hepatitis B; Immunization - hepatitis B
InformationThe vaccine is made from inactivated whole virus of hepatitis B. The inactive virus stimulates your body to produce antibodies to fight the hepatitis B virus.
WHO SHOULD GET THIS VACCINE
The hepatitis B vaccine is given to children as a series of three injections (shots).
For infants who do not receive the first shot until 4 to 8 weeks, the second shot is given at 4 months and the third at 6 to 16 months. In either instance, the second and third shots are given along with other routine childhood immunizations.
Adolescents who have not been vaccinated should begin the hepatitis B vaccine series at the earliest possible date.
Adults or children who have not already received the vaccine and should receive the vaccine if they meet any of the following criteria:
A vaccine for adults called Twinrix provides protection against both hepatitis A and B. It is given in 3 doses.
RISKS AND SIDE EFFECTS
Most infants who receive the hepatitis B vaccine have no side effects. Others may have minor problems, such as soreness and redness at the injection site or a mild fever. Serious problems are rare and are mainly due to allergic reactions to a component of the vaccine.
CONSIDERATIONS
If the child is ill with something more serious than a cold, the hepatitis B vaccine may be delayed.
If the child has a severe allergic reaction to baker's yeast, they should not receive this vaccine.
If severe allergic reaction occurs after receiving the vaccine, no further hepatitis B vaccines should be given to the child.
CALL YOUR PRIMARY HEALTH CARE PROVIDER IF:
American Academy of Pediatrics Committee on Infectious Diseases. Recommended immunization schedules for children and adolescents--United States, 2008. Pediatrics. 2008 Jan;121(1):219-20.
Centers for Disease Control and Prevention. Recommended adult immunization schedule---United States, 2009. MMWR. January 9, 2009;57(53);Q1-Q4.
Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0 through 18 years---United States, 2009. MMWR. January 2, 2009;57(51&52);Q1-Q4.
The hepatitis B vaccine protects against hepatitis B, a serious viral disease that damages the liver. This vaccine is one of the recommended childhood immunizations, but many adults also need to be vaccinated.
Alternative NamesVaccine - hepatitis B; Immunization - hepatitis B
InformationThe vaccine is made from the inactivated (dead) hepatitis B virus. After you get a hepatitis B vaccine, your body learns to attack the hepatitis B virus if you are exposed to it. This means you are very unlikely to get sick with hepatitis B.
Because no vaccine is 100% effective, it is still possible to get hepatitis B, even after you have been completely vaccinated.
WHO SHOULD GET THIS VACCINE
The hepatitis B vaccine is given to children as a series of three injections (shots).
Infants who do not get the first shot until 4 to 8 weeks, will get the second shot at 4 months and the third shot at 6 to 16 months. Either way, the second and third shots are given along with other routine childhood immunizations.
Adolescents who have not been vaccinated should begin the three-shot hepatitis B vaccine series at the earliest possible date.
Adults or children who have not already received the vaccine should get the vaccine series if they:
Adults can receive the hepatitis B vaccine only, or a vaccine called Twinrix that protects against both hepatitis A and B. Either series is given in 3 doses.
RISKS AND SIDE EFFECTS
Most infants who receive the hepatitis B vaccine have no side effects. Others may have minor problems, such as soreness and redness at the injection site or a mild fever. Serious problems are rare and are mainly due to allergic reactions to a part of the vaccine.
CONSIDERATIONS
If the child is ill with something more serious than a cold, the hepatitis B vaccine may be delayed.
Children who have had a severe allergic reaction to baker's yeast should not receive this vaccine.
A child who has a severe allergic reaction after receiving the vaccine should not get another hepatitis B vaccine.
CALL YOUR HEALTH CARE PROVIDER IF:
Centers for Disease Control and Prevention. 2012 immunization schedules for children 0 to 18 years of age. October 25, 2011.
Centers for Disease Control and Prevention. Recommended adult immunization schedule. United States. 2011 Proposed Revisions. Advisory Committee on Immunization Practices. October 28, 2010.
Reviewed ByReview Date: 12/18/2010
David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
Since Hepatitis B vaccine only protects against Hepatitis B, the only thing the vaccine controls is Hepatitis B infections.
Once you have had Hepatitis B there is no need for a Hepatitis B vaccine. The vaccine is only effective for those who have not had the disease, it is used to prevent a hepatitis B infection.
Yes, the hepatitis B vaccine can be given to someone with hepatitis B. It is still recommended in order to prevent reinfection with other strains of the virus and to protect against potential complications of chronic hepatitis B.
There's a Hepatitis B vaccine that can prevent it.
No. It's not a live vaccine.
Hepatitis C and hepatitis E have no vaccine to prevent the disease. Although there is no vaccine to prevent hepatitis D, you can only get this type if you're also infected with type B. Therefore, hepatitis B vaccine indirectly prevents hepatitis D.
There is a vaccine for it.
yes
One someone has hepatitis b the vaccine for them is of no use True or false?
JENNIFER TUNG has written: 'EFFICACY OF COMBINED HEPATITIS A AND HEPATITIS B (TWINRIX) VACCINE COMPARED WITH HEPATITIS B VACCINE ALONE IN PROVIDING SEROPROTECTION VS. HEPATITIS B IN HEMODIALYSIS PATIENTS'
no
Hepatitis B vaccine is safe and effective on 50 percent of all patients who are vaccinated.